TRUNCAL TUMOR SITE IS ASSOCIATED WITH HIGH-RISK OF MULTIPLE BASAL-CELL CARCINOMA AND IS INFLUENCED BY GLUTATHIONE-S-TRANSFERASE, GSTT1, ANDCYTOCHROME-P450, CYP1A1 GENOTYPES, AND THEIR INTERACTION
Jt. Lear et al., TRUNCAL TUMOR SITE IS ASSOCIATED WITH HIGH-RISK OF MULTIPLE BASAL-CELL CARCINOMA AND IS INFLUENCED BY GLUTATHIONE-S-TRANSFERASE, GSTT1, ANDCYTOCHROME-P450, CYP1A1 GENOTYPES, AND THEIR INTERACTION, Journal of investigative dermatology, 108(4), 1997, pp. 519-522
Basal cell carcinoma (BCC) places increasing burdens on clinicians; in
cidence is rising and patients may develop multiple primary tumors, Al
though UV exposure is critical, many patients develop tumors at less-e
xposed sites, such as the trunk, suggesting a genetic predisposition,
We previously showed that polymorphism in loci encoding the detoxifyin
g enzymes, glutathione S-transferase (GSTM1, GSTM3, GSTT1) and cytochr
ome P450 (CYP2D6, CYP1A1) influences susceptibility to BCC, We now des
cribe a case-control approach in 345 patients with BCC that examines t
he role of these polymorphisms and patient characteristics (age, gende
r, skin type, hair color, eye color, smoking, occupation) in determini
ng susceptibility to truncal tumors, GST and CYP genotypes were identi
fied using polymerase chain reaction-based methods. Patients with one
or more truncal tumors were significantly younger (p = 0.0170) than th
ose with no truncal tumors, Male gender also appeared more common in t
he truncal tumor group, although this did not achieve significance (p
= 0.0925), Patients whose first tumor was truncal had significantly mo
re tumors (p = 0.0297). GSTT1 null (p = 0.0245, odds ratio 2.24) and C
YP1A1 Ile/Ile (p = 0.0386, odds ratio 2.86) were associated with trunc
al site after correction for age and gender, The combination, GSTT1 nu
ll and CYP1A1 Ile/Ile. was particularly significant (p = 0.0059, odds
ratio = 2.95), These effects were present after correction for tumor n
umbers, These data show first, patients with truncal tumors constitute
a high-risk group for BCC, second, a significant genetic influence on
BCC site, and third, a significant interaction between GSTT1 and CYP1
A1 genotypes.